Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 13, 2017 09:12 ET | Source: Aequus Pharmaceuticals

Aequus Raises $5.2 Million Through Bought Deal Financing Including Full Exercise of the Over-Allotment Option

VANCOUVER, BC--(Marketwired - March 13, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
March 02, 2017 08:00 ET | Source: Aequus Pharmaceuticals

Aequus Licenses Rights to Cannabinoid Transdermal Patch to Treat Neurological Disorders

VANCOUVER, BC--(Marketwired - March 02, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that through a previously announced Research...
February 14, 2017 08:00 ET | Source: Aequus Pharmaceuticals

Aequus Successfully Completes Dosing in Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch

VANCOUVER, BC--(Marketwired - February 14, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
February 01, 2017 09:00 ET | Source: Aequus Pharmaceuticals

Aequus Receives Non-Dilutive Funding from the Government of Canada to Support Aripiprazole Patch Development

VANCOUVER, BC--(Marketwired - February 01, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), today announced funding of up to CAD$100,000 from the...
January 09, 2017 09:00 ET | Source: Aequus Pharmaceuticals

Aequus Initiates Second Proof of Concept Clinical Trial of Transdermal Aripiprazole Patch

VANCOUVER, BC--(Marketwired - January 09, 2017) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), announced today that it has received approval from Health...
December 01, 2016 08:00 ET | Source: Aequus Pharmaceuticals Inc.

Aequus Obtains Public Reimbursement for Vistitan in Two Additional Provinces: Alberta and Manitoba

VANCOUVER, BC--(Marketwired - December 01, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
November 30, 2016 08:00 ET | Source: Aequus Pharmaceuticals

Aequus Provides Q3 2016 Financial Highlights With Substantial Increase in Quarter Over Quarter Revenues

VANCOUVER, BC--(Marketwired - November 30, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
November 17, 2016 09:00 ET | Source: Aequus Pharmaceuticals

Aequus Prepares for Proof of Concept Clinical Study for Transdermal Anti-Nausea Diclegis Program

VANCOUVER, BC--(Marketwired - November 17, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company") announced today that is has entered into a service...
October 17, 2016 09:00 ET | Source: Aequus Pharmaceuticals

Aequus Advances Clinical Development of Transdermal Aripiprazole Patch

VANCOUVER, BC--(Marketwired - October 17, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...
October 03, 2016 12:37 ET | Source: Aequus Pharmaceuticals Inc.

Aequus Partners With Camargo to Support US Regulatory Strategy for Development Programs

VANCOUVER, BC--(Marketwired - October 03, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on...